Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report

PURPOSE: Remdesivir is the first line hospital treatment of the SARS-CoV-2 infection. Despite its widespread use during COVID-19 pandemic, a limited number of data, also conflicting, are available about the frequency of cardiological side-effects. Additionally, identification of patients who belong...

Descripción completa

Detalles Bibliográficos
Autores principales: Guziejko, Katarzyna, Talalaj, Jaroslaw, Chorazy, Monika, Groth, Monika, Moniuszko-Malinowska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196856/
https://www.ncbi.nlm.nih.gov/pubmed/35701724
http://dx.doi.org/10.1007/s15010-022-01854-3
_version_ 1784727273724706816
author Guziejko, Katarzyna
Talalaj, Jaroslaw
Chorazy, Monika
Groth, Monika
Moniuszko-Malinowska, Anna
author_facet Guziejko, Katarzyna
Talalaj, Jaroslaw
Chorazy, Monika
Groth, Monika
Moniuszko-Malinowska, Anna
author_sort Guziejko, Katarzyna
collection PubMed
description PURPOSE: Remdesivir is the first line hospital treatment of the SARS-CoV-2 infection. Despite its widespread use during COVID-19 pandemic, a limited number of data, also conflicting, are available about the frequency of cardiological side-effects. Additionally, identification of patients who belong to the risk groups for cardiovascular complications of antiviral treatment is difficult. CASE DESCRIPTION: Case description We present a case of a 26 year old patient, a soldier with COVID-19 and no comorbidities, who developed marked sinus bradycardia during remdesivir therapy. The bradycardia resolved few days after the end of antiviral treatment. CONCLUSION: Our case emphasizes the key importance of the correct monitoring of patients receiving remdesivir, even those who do not have pre-existing heart conditions.
format Online
Article
Text
id pubmed-9196856
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91968562022-06-17 Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report Guziejko, Katarzyna Talalaj, Jaroslaw Chorazy, Monika Groth, Monika Moniuszko-Malinowska, Anna Infection Case Report PURPOSE: Remdesivir is the first line hospital treatment of the SARS-CoV-2 infection. Despite its widespread use during COVID-19 pandemic, a limited number of data, also conflicting, are available about the frequency of cardiological side-effects. Additionally, identification of patients who belong to the risk groups for cardiovascular complications of antiviral treatment is difficult. CASE DESCRIPTION: Case description We present a case of a 26 year old patient, a soldier with COVID-19 and no comorbidities, who developed marked sinus bradycardia during remdesivir therapy. The bradycardia resolved few days after the end of antiviral treatment. CONCLUSION: Our case emphasizes the key importance of the correct monitoring of patients receiving remdesivir, even those who do not have pre-existing heart conditions. Springer Berlin Heidelberg 2022-06-14 2022 /pmc/articles/PMC9196856/ /pubmed/35701724 http://dx.doi.org/10.1007/s15010-022-01854-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Guziejko, Katarzyna
Talalaj, Jaroslaw
Chorazy, Monika
Groth, Monika
Moniuszko-Malinowska, Anna
Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report
title Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report
title_full Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report
title_fullStr Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report
title_full_unstemmed Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report
title_short Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report
title_sort remdesivir-induced bradycardia in a 26-year-old patient with covid-19: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196856/
https://www.ncbi.nlm.nih.gov/pubmed/35701724
http://dx.doi.org/10.1007/s15010-022-01854-3
work_keys_str_mv AT guziejkokatarzyna remdesivirinducedbradycardiaina26yearoldpatientwithcovid19acasereport
AT talalajjaroslaw remdesivirinducedbradycardiaina26yearoldpatientwithcovid19acasereport
AT chorazymonika remdesivirinducedbradycardiaina26yearoldpatientwithcovid19acasereport
AT grothmonika remdesivirinducedbradycardiaina26yearoldpatientwithcovid19acasereport
AT moniuszkomalinowskaanna remdesivirinducedbradycardiaina26yearoldpatientwithcovid19acasereport

Ejemplares similares